Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort.

Francesco Molica ColellaGaetano ZizzoVincenzo ParrinoMaria Teresa FilosaRiccardo CavaliereFrancesco FazioAldo Biagio Molica ColellaAntonino Mazzone

Published in: Advances in rheumatology (London, England) (2023)

In a real-world setting, secukinumab confirmed great effectiveness and safety in both AS and PsA patients. The influence of gender on treatment response deserves further attention.

Keyphrases

ankylosing spondylitis
rheumatoid arthritis
end stage renal disease
disease activity
newly diagnosed
prostate cancer
chronic kidney disease
ejection fraction
systemic lupus erythematosus
peritoneal dialysis
prognostic factors
radical prostatectomy
mental health
clinical trial